Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 258 -8.00 (-3.01%)
As of 07/25/2025 11:50 AM Eastern

HCM vs. ITH, SOPH, INDV, GRI, SLS, ERGO, SLN, AMYT, BMY, and OGN

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), Indivior (INDV), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs. Its Competitors

HUTCHMED (LON:HCM) and Ithaca Energy (LON:ITH) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

Ithaca Energy has higher revenue and earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Ithaca Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HUTCHMED£771.01M3.63-£52.98M-£3.92-65.85
Ithaca Energy£3.55B0.98£230.29M£8.7619.16

Ithaca Energy has a net margin of 6.48% compared to HUTCHMED's net margin of -6.87%. Ithaca Energy's return on equity of 4.55% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
HUTCHMED-6.87% -5.71% -5.90%
Ithaca Energy 6.48%4.55%0.18%

In the previous week, Ithaca Energy had 2 more articles in the media than HUTCHMED. MarketBeat recorded 2 mentions for Ithaca Energy and 0 mentions for HUTCHMED. Ithaca Energy's average media sentiment score of 0.38 beat HUTCHMED's score of 0.00 indicating that Ithaca Energy is being referred to more favorably in the news media.

Company Overall Sentiment
HUTCHMED Neutral
Ithaca Energy Neutral

36.5% of HUTCHMED shares are owned by institutional investors. Comparatively, 3.7% of Ithaca Energy shares are owned by institutional investors. 39.0% of HUTCHMED shares are owned by insiders. Comparatively, 89.6% of Ithaca Energy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Ithaca Energy beats HUTCHMED on 10 of the 12 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.80B£2.18B£5.69B£3.02B
Dividend Yield4.63%2.92%4.58%5.02%
P/E Ratio-65.854.1928.10160.65
Price / Sales3.63587.23432.44278,114.42
Price / Cash2.4910.3536.2227.97
Price / Book2.9511.028.664.70
Net Income-£52.98M£21.15B£3.25B£5.90B
7 Day PerformanceN/A1.55%4.23%0.36%
1 Month Performance16.74%5.93%10.52%7.05%
1 Year Performance-11.64%2.69%34.41%73.19%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 258
-3.0%
N/A-9.2%£2.80B£771.01M-65.851,760
ITH
Ithaca Energy
N/AGBX 167.20
+1.2%
N/A+33.4%£3.49B£3.55B19.09220Gap Down
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
INDV
Indivior
2.8958 of 5 stars
GBX 1,219
+3.0%
GBX 1,650
+35.4%
+28.8%£1.90B£1.40B-1,010.731,000Gap Up
GRI
Grainger
3.1085 of 5 stars
GBX 207.50
-1.0%
GBX 317.50
+53.0%
-11.7%£1.53B£276.05M-1,383.33372Dividend Increase
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.4695 of 5 stars
GBX 511
+1.0%
GBX 825
+61.4%
-28.8%£412.34M£382.40M10.9334,300
OGN
Origin Enterprises
N/AGBX 3.75
flat
N/A+21.2%£395.95M£183.08B10.8410,000Dividend Increase

Related Companies and Tools


This page (LON:HCM) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners